Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Glucagon receptor agonist - Wikipedia

   en.wikipedia.org/wiki/Glucagon_receptor_agonist

   Combination GLP-1/glucagon receptor agonists provide the thermogenic benefits of glucagon activation while almost eliminating hyperglycemia induced by glucagon receptor activation. Several such drugs have reached human trials for obesity, diabetes, and non-alcoholic fatty liver disease but adverse effects have hampered development. [2]

3. GLP1 poly-agonist peptides - Wikipedia

   en.wikipedia.org/wiki/GLP1_poly-agonist_peptides

   GLP1 poly-agonist peptides. GLP1 poly-agonist peptides [1] are a class of drugs that activate multiple peptide hormone receptors including the glucagon-like peptide-1 (GLP-1) receptor. These drugs are developed for the same indications as GLP-1 receptor agonists —especially obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

4. Bariatric surgery better for weight loss than GLP-1 drugs ...

   www.aol.com/bariatric-surgery-better-weight-loss...

   When looking at the results of weight loss surgery, the researchers found a total weight loss of nearly 32% for gastric bypass and 29% for sleeve gastrectomy one year after surgery. Study ...

5. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 receptor agonist. Glucagon-like peptide-1 (GLP-1) receptor agonists, also known as GLP-1 analogs, GLP-1DAs or incretin mimetics, [ 1] are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1 that is released by the gut after ...

6. How weight loss drugs are showing promise beyond ... - AOL

   www.aol.com/weight-loss-drugs-showing-promise...

   GLP-1 agonists, a class of medication typically used to treat Type 2 diabetes and obesity, have been available since 2005, but only in the… How weight loss drugs are showing promise beyond ...

7. NC Medicaid to cover weight-loss drugs like Wegovy, after ...

   www.aol.com/news/nc-medicaid-cover-weight-loss...

   These drugs, which work by making people stay fuller for longer, have been found to help people lose over 10% of their body weight. The FDA has approved for weight loss GLP-1 drugs Wegovy and ...

8. From the Greeks to GLP-1s: The Complete History of Weight ...

   www.aol.com/greeks-glp-1s-complete-history...

   The approval of the first GLP-1 injectable medication was a huge development and game-changer for weight loss treatment. Initially, weight loss was only noted as a potential side effect of the drug.

9. Albiglutide - Wikipedia

   en.wikipedia.org/wiki/Albiglutide

   72 971.34 g·mol −1. Albiglutide (trade names Eperzan in Europe and Tanzeum in the US) is a glucagon-like peptide-1 agonist (GLP-1 agonist) drug marketed by GlaxoSmithKline (GSK) for treatment of type 2 diabetes . As of 2017 it is unclear if it affects a person's risk of death. [ 2] GSK has announced that it intends to withdraw the drug from ...